Healthcare Equipment and Supplies
Company Overview of OrthoSensor, Inc.
OrthoSensor, Inc. develops and commercializes intelligent orthopedic devices that monitor, assess, and communicate medical information about implant placement and performance to surgeons and hospitals. Its product platforms include OrthoSensor Surgical platform to reduce implant failures by addressing the root causes, such as poor soft tissue balance and malalignment; OrthoSensor Implantables platform to monitor various parameters throughout the life cycle of an implant; and OrthoSensor Analytics platform that enables evidence-based medicine by capturing implant data and links it to patients, physicians, and procedures. The company also provides electronic sensor modules to be embedded into ...
1855 Griffin Road
Dania Beach, FL 33004-2200
Founded in 2007
Key Executives for OrthoSensor, Inc.
Chief Executive Officer and President
Vice President of Information Technology
Compensation as of Fiscal Year 2014.
OrthoSensor, Inc. Key Developments
OrthoSensor, Inc. Presents at The 8th Annual SEMDA Conference, May-08-2014 03:45 PM
May 5 14
OrthoSensor, Inc. Presents at The 8th Annual SEMDA Conference, May-08-2014 03:45 PM. Venue: Waverly Hotel and Convention Center, Atlanta, Georgia, United States. Speakers: Jay A. Pierce, Chief Executive Officer, President and Director.
OrthoSensor, Inc. Announces One-Year Results of VERASENSE Multicenter Evaluation
Mar 12 14
OrthoSensor, Inc. announced that one-year results of the VERASENSE Multicenter Evaluation were first presented during the American Academy of Orthopaedic Surgeons (AAOS) 2014 Annual Meeting in New Orleans, LA. Details of the one-year clinical outcomes presentation included: At one year, the average total KSS score of balanced patients exceeded that of unbalanced patients by 23.3 points (P<0.001); 179+/-17.2 and 156+/-23.4 for the balanced and unbalanced groups, respectively. The balanced group average score for KSS pain and function were 96.4 and 82.4 respectively; the unbalanced group scored 87.8 and 68.3 points for pain and function. The disparity between the balanced and unbalanced patients' pain and function scores were highly statistically significant (P<0.001, P=0.022). The balanced group averaged 8 points greater improvement in WOMAC scores than the unbalanced group (10+/-11.8 and 18+/-17 for balanced and unbalanced patients, respectively). It is important to note that the WOMAC is scored with an inverse scale; lower scores indicate more improvement. The balanced group's average activity level score was 48.6, which corresponds with the light to moderate labor categories (tennis, light jogging, heavy yard work). The unbalanced patient's average activity level score was 26.7, which corresponds to the upper limits of the semi-sedentary range (light housework, walking for limited distances). The difference between the average scores was also statistically significant (P=0.015).
Smith & Nephew and OrthoSensor to Co-Market VERASENSE(TM) Sensor Assisted Surgery with JOURNEY(TM) II and LEGION(TM) Total Knee Replacements
Mar 10 14
Smith & Nephew and OrthoSensor announced an agreement that will enable surgeons to benefit from OrthoSensor's VERASENSE Sensor Assisted Surgery Technology for soft tissue balancing when implanting Smith & Nephew's JOURNEY(TM) II and LEGION(TM) Total Knee Systems. VERASENSE utilizes advanced sensor technologies to enable evidence-based surgical decisions regarding component position, limb alignment and soft tissue balance to optimize outcomes in total knee replacement. Research shows that patients whose knees have been balanced with the VERASENSE Knee System report less pain and experience greater improvements in function, activity levels and satisfaction post-operatively. Historically, soft tissue balancing has been accomplished by subjective surgeon feel. The VERASENSE Knee System now provides surgeons with real-time, quantitative data that enables evidence-based, intraoperative decisions regarding component position, limb alignment and soft tissue releases to achieve balance and stability through a full range of motion. At one-year, 97% of patients whose knees were quantifiably balanced using the VERASENSE Knee System said they were 'satisfied' to 'very satisfied' with the outcome of their total knee arthroplasty (TKA), a marked improvement over the average 81% satisfaction reported in literature.
Similar Private Companies By Industry
Recent Private Companies Transactions
June 10, 2014